scholarly journals Prediction of final tumor response to preoperative chemotherapy by Tc-99m MIBI imaging at the middle of chemotherapy in malignant bone and soft tissue tumors: Comparison with Tl-201 imaging

2008 ◽  
Vol 26 (3) ◽  
pp. 411-418 ◽  
Author(s):  
Junichi Taki ◽  
Takahiro Higuchi ◽  
Hisashi Sumiya ◽  
Hiroyuki Tsuchiya ◽  
Hiroshi Minato ◽  
...  
2010 ◽  
Vol 35 (3) ◽  
pp. 154-159 ◽  
Author(s):  
Junichi Taki ◽  
Anri Inaki ◽  
Hiroshi Wakabayashi ◽  
Hisashi Sumiya ◽  
Hiroyuki Tsuchiya ◽  
...  

Cancer ◽  
2002 ◽  
Vol 94 (5) ◽  
pp. 1557-1564 ◽  
Author(s):  
Christoph Kettelhack ◽  
Minette v. Wickede ◽  
Thomas Vogl ◽  
Ulrike Schneider ◽  
Peter Hohenberger

2012 ◽  
Vol 37 (1) ◽  
pp. 1-8 ◽  
Author(s):  
Hiroshi Wakabayashi ◽  
Junichi Taki ◽  
Anri Inaki ◽  
Hisashi Sumiya ◽  
Yoh Zen ◽  
...  

Author(s):  
D. C. Swartzendruber ◽  
Norma L. Idoyaga-Vargas

The radionuclide gallium-67 (67Ga) localizes preferentially but not specifically in many human and experimental soft-tissue tumors. Because of this localization, 67Ga is used in clinical trials to detect humar. cancers by external scintiscanning methods. However, the fact that 67Ga does not localize specifically in tumors requires for its eventual clinical usefulness a fuller understanding of the mechanisms that control its deposition in both malignant and normal cells. We have previously reported that 67Ga localizes in lysosomal-like bodies, notably, although not exclusively, in macrophages of the spocytaneous AKR thymoma. Further studies on the uptake of 67Ga by macrophages are needed to determine whether there are factors related to malignancy that might alter the localization of 67Ga in these cells and thus provide clues to discovering the mechanism of 67Ga localization in tumor tissue.


2020 ◽  
Vol 24 (06) ◽  
pp. 667-675
Author(s):  
Violeta Vasilevska Nikodinovska ◽  
Slavcho Ivanoski ◽  
Milan Samardziski ◽  
Vesna Janevska

AbstractBone and soft tissue tumors are a largely heterogeneous group of tumors. Biopsy of musculoskeletal (MSK) tumors is sometimes a challenging procedure. Although the open biopsy is still considered the gold standard for the biopsy of MSK lesions, core needle biopsy can replace it in most cases, with similar accuracy and a low complication rate. The biopsy should be performed in a tertiary sarcoma center where the multidisciplinary team consists of at minimum a tumor surgeon, an MSK pathologist, and an MSK radiologist who can assess all steps of the procedure. Several factors can influence the success of the biopsy including the lesion characteristics, the equipment, and the method used for the procedure. This review highlights some of the important aspects regarding the biopsy of the MSK tumors, with special attention to imaging a guided core needle biopsy and highlighting some of the recent advancements and controversies in the field.


1994 ◽  
Vol 35 (4) ◽  
pp. 367-370 ◽  
Author(s):  
J. Gelineck ◽  
J. Keller ◽  
O. Myhre Jensen ◽  
O. Steen Nielsen ◽  
T. Christensen

Sign in / Sign up

Export Citation Format

Share Document